Annual ROE
-481.35%
+0.14%+0.03%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual return on equity is -481.35%, with the most recent change of +0.14% (+0.03%) on December 31, 2023.
- During the last 3 years, AVDL annual ROE has fallen by -491.91% (-4658.24%).
- AVDL annual ROE is now -523.02% below its all-time high of 113.79%, reached on December 31, 2019.
Performance
AVDL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-86.15%
+22.30%+20.56%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly return on equity is -86.15%, with the most recent change of +22.30% (+20.56%) on September 30, 2024.
- Over the past year, AVDL quarterly ROE has increased by +198.26% (+69.71%).
- AVDL quarterly ROE is now -111.40% below its all-time high of 755.56%, reached on March 31, 2023.
Performance
AVDL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVDL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.0% | +69.7% |
| 3 y3 years | -4658.2% | +91.8% |
| 5 y5 years | -123.1% | +91.8% |
AVDL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -648.6% | +0.0% | -111.4% | +91.8% |
| 5 y | 5-year | -523.0% | +0.0% | -111.4% | +91.8% |
| alltime | all time | -523.0% | +56.7% | -111.4% | +97.4% |
Avadel Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -86.15%(-20.6%) |
| Jun 2024 | - | -108.45%(-47.3%) |
| Mar 2024 | - | -205.66%(-27.7%) |
| Dec 2023 | -481.35%(-0.0%) | -284.41%(-35.0%) |
| Sep 2023 | - | -437.63%(-58.3%) |
| Jun 2023 | - | -1048.41%(-238.8%) |
| Mar 2023 | - | 755.56%(-206.1%) |
| Dec 2022 | -481.49%(+648.8%) | -711.81%(+133.1%) |
| Sep 2022 | - | -305.35%(+58.4%) |
| Jun 2022 | - | -192.79%(+108.3%) |
| Mar 2022 | - | -92.56%(+42.4%) |
| Dec 2021 | -64.30%(-708.9%) | -65.00%(+34.9%) |
| Sep 2021 | - | -48.20%(+32.7%) |
| Jun 2021 | - | -36.32%(+794.6%) |
| Mar 2021 | - | -4.06%(-159.9%) |
| Dec 2020 | 10.56%(-90.7%) | 6.78%(-71.3%) |
| Sep 2020 | - | 23.64%(-64.0%) |
| Jun 2020 | - | 65.62%(-67.4%) |
| Mar 2020 | - | 201.31%(+26.5%) |
| Dec 2019 | 113.79%(-152.7%) | 159.13%(-104.8%) |
| Sep 2019 | - | -3322.04%(+685.5%) |
| Jun 2019 | - | -422.91%(+97.7%) |
| Mar 2019 | - | -213.96%(+43.5%) |
| Dec 2018 | -215.72%(-301.7%) | -149.05%(+210.5%) |
| Sep 2018 | - | -48.01%(+1718.6%) |
| Jun 2018 | - | -2.64%(-107.1%) |
| Mar 2018 | - | 37.20%(-60.8%) |
| Dec 2017 | 106.97%(-244.1%) | 94.84%(-27.4%) |
| Sep 2017 | - | 130.55%(+75.8%) |
| Jun 2017 | - | 74.24%(-514.1%) |
| Mar 2017 | - | -17.93%(-76.6%) |
| Dec 2016 | -74.24%(-183.5%) | -76.56%(-234.2%) |
| Sep 2016 | - | 57.04%(+33.0%) |
| Jun 2016 | - | 42.88%(-24.0%) |
| Mar 2016 | - | 56.43%(-52.3%) |
| Dec 2015 | 88.90%(-108.0%) | 118.36%(-139.3%) |
| Sep 2015 | - | -301.09%(+122.4%) |
| Jun 2015 | - | -135.39%(+28.1%) |
| Mar 2015 | - | -105.71%(-52.6%) |
| Dec 2014 | -1111.21%(+171.7%) | -223.25%(+28.2%) |
| Sep 2014 | - | -174.13%(-28.1%) |
| Jun 2014 | - | -242.32%(-48.3%) |
| Mar 2014 | - | -468.41%(-62.5%) |
| Dec 2013 | -408.97%(+3718.6%) | -1247.46%(+233.6%) |
| Sep 2013 | - | -373.96%(+90.7%) |
| Jun 2013 | - | -196.07%(+352.7%) |
| Mar 2013 | - | -43.31%(+302.5%) |
| Dec 2012 | -10.71%(-59.7%) | -10.76%(-78.3%) |
| Sep 2012 | - | -49.65%(+138.9%) |
| Jun 2012 | - | -20.78%(+73.5%) |
| Mar 2012 | - | -11.98%(-55.1%) |
| Dec 2011 | -26.55%(+20.1%) | -26.69%(+123.9%) |
| Sep 2011 | - | -11.92%(-55.7%) |
| Jun 2011 | - | -26.92%(-4.6%) |
| Mar 2011 | - | -28.21%(+16.9%) |
| Dec 2010 | -22.11% | -24.14%(-44.4%) |
| Sep 2010 | - | -43.45%(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -40.23%(+12.5%) |
| Mar 2010 | - | -35.76%(+51.6%) |
| Dec 2009 | -24.49%(+4.6%) | -23.59%(+38.4%) |
| Sep 2009 | - | -17.05%(+17.7%) |
| Jun 2009 | - | -14.49%(+5.7%) |
| Mar 2009 | - | -13.71%(-39.2%) |
| Dec 2008 | -23.42%(-60.4%) | -22.54%(-19.0%) |
| Sep 2008 | - | -27.82%(-28.7%) |
| Jun 2008 | - | -39.01%(-29.0%) |
| Mar 2008 | - | -54.98%(-9.6%) |
| Dec 2007 | -59.12%(+34.1%) | -60.85%(+5.8%) |
| Sep 2007 | - | -57.51%(+4.2%) |
| Jun 2007 | - | -55.17%(+19.5%) |
| Mar 2007 | - | -46.16%(+3.2%) |
| Dec 2006 | -44.09%(+63.8%) | -44.73%(+3.7%) |
| Sep 2006 | - | -43.13%(+3.2%) |
| Jun 2006 | - | -41.79%(+9.1%) |
| Mar 2006 | - | -38.32%(+45.6%) |
| Dec 2005 | -26.92%(-324.9%) | -26.32%(+112.9%) |
| Sep 2005 | - | -12.36%(-976.6%) |
| Jun 2005 | - | 1.41%(-83.5%) |
| Mar 2005 | - | 8.54%(-35.3%) |
| Dec 2004 | 11.97%(-259.2%) | 13.19%(+137.7%) |
| Sep 2004 | - | 5.55%(+3164.7%) |
| Jun 2004 | - | 0.17%(-80.5%) |
| Mar 2004 | - | 0.87%(-104.6%) |
| Dec 2003 | -7.52%(-124.8%) | -19.02%(-52.3%) |
| Sep 2003 | - | -39.89%(+234.1%) |
| Jun 2003 | - | -11.94%(+0.4%) |
| Mar 2003 | - | -11.89%(-487.3%) |
| Dec 2002 | 30.36%(-197.2%) | 3.07%(-37.9%) |
| Sep 2002 | - | 4.94%(-115.0%) |
| Jun 2002 | - | -32.95%(+13.3%) |
| Mar 2002 | - | -29.09%(+14.7%) |
| Dec 2001 | -31.25%(-67.1%) | -25.37%(-470.9%) |
| Sep 2001 | - | 6.84%(+81.4%) |
| Jun 2001 | - | 3.77%(-47.4%) |
| Mar 2001 | - | 7.17%(-119.0%) |
| Dec 2000 | -94.85%(+90.2%) | -37.83%(-44.2%) |
| Sep 2000 | - | -67.85%(-24.2%) |
| Jun 2000 | - | -89.53%(-20.1%) |
| Mar 2000 | - | -112.11%(+152.6%) |
| Dec 1999 | -49.86%(+2.4%) | -44.39%(-24.9%) |
| Sep 1999 | - | -59.12%(+7.8%) |
| Jun 1999 | - | -54.82%(+17.3%) |
| Mar 1999 | - | -46.74%(-22.1%) |
| Dec 1998 | -48.70%(+33.9%) | -60.01%(+26.4%) |
| Sep 1998 | - | -47.47%(-10.3%) |
| Jun 1998 | - | -52.92%(-15.4%) |
| Mar 1998 | - | -62.58%(+11.8%) |
| Dec 1997 | -36.36%(+21.7%) | -55.99%(+54.0%) |
| Sep 1997 | - | -36.36%(+21.7%) |
| Jun 1997 | - | -29.87%(-2.8%) |
| Mar 1997 | - | -30.74%(-51.9%) |
| Dec 1996 | -29.87% | -63.89%(-118.1%) |
| Sep 1996 | - | 353.33%(+35.9%) |
| Jun 1996 | - | 260.00%(+160.0%) |
| Mar 1996 | - | 100.00% |
FAQ
- What is Avadel Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual ROE year-on-year change?
- What is Avadel Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly ROE year-on-year change?
What is Avadel Pharmaceuticals annual return on equity?
The current annual ROE of AVDL is -481.35%
What is the all time high annual ROE for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual return on equity is 113.79%
What is Avadel Pharmaceuticals annual ROE year-on-year change?
Over the past year, AVDL annual return on equity has changed by +0.14% (+0.03%)
What is Avadel Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AVDL is -86.15%
What is the all time high quarterly ROE for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly return on equity is 755.56%
What is Avadel Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AVDL quarterly return on equity has changed by +198.26% (+69.71%)